21st Century Oncology, Inc., the largest provider of integrated cancer care services, announced that it has appointed Matthew Anderson as the executive vice president, strategic initiatives. In this newly-created role, Anderson will oversee the development and execution of programs that further the company's core mission of delivering high quality, efficient care to its patients. Anderson will report directly to William Spalding, the company's president and chief executive officer.

"Based on my experience working closely with Matt at PharMEDium Health Care Holdings, I am confident that his dynamic leadership skills will be invaluable as we embark on the next phase of our evolution," said Spalding. "With his experience, expertise and passion, Matt is the ideal fit for this new role, and the entire 21st Century Oncology leadership team looks forward to working closely with Matt as we navigate our growth opportunities in today's healthcare reform environment."

Anderson, a CPA, brings more than 20 years of experience in corporate finance and accounting in the health care industry. Prior to 21st Century Oncology, Anderson spent nine years in various leadership roles at PharMEDium, including serving as the company's chief financial officer, and was previously director of finance for Cardinal Health. He earned his MBA from the Kellogg School of Management at Northwestern University, MS in accountancy from DePaul University and BA in economics from Western Illinois University.

About 21st Century Oncology Holdings, Inc.

21st Century Oncology Holdings, Inc., is the largest global provider of integrated cancer care services. The Company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of December 31, 2015, the Company operated 181 treatment centers, including 145 centers located in 17 U.S. states and 36 centers located in seven countries in Latin America.